Interest groups spent a record $4.2 billion lobbying federal lawmakers in 2023, led by the pharmaceutical and health products industries, according to a new report by OpenSecrets. According to the D.C.-based nonprofit, which tracks money in politics, “health companies spent more than any other sector in 2023 with federal lobbying spending topping $739 million for
Share this:

In 2023, interest groups set a new spending record on federal lobbying, totaling $4.2 billion, with the pharmaceutical and health products industries leading the expenditures. OpenSecrets, a D.C.-based nonprofit that monitors political finances, reported that health companies outspent other sectors, contributing over $739 million to federal lobbying efforts. This expenditure trend extends to state levels, a continuation from 2019.

The U.S. Chamber of Commerce emerged as the highest spender in federal lobbying, allocating $69 million, followed by the National Association of Realtors at $52 million. Interestingly, both groups reduced their spending compared to 2022.

OpenSecrets highlighted a shift in lobbying focus to state lawmakers, particularly on contentious issues like abortion, guns, and gambling, due to congressional gridlock. State lobbying expenditures in 2023 were estimated at $1.4 billion, matching the 2015 figures but showing a decrease from the $1.8 billion peak in 2022.

The combined federal and state lobbying spending in 2023 amounted to $5.6 billion, slightly lower than the 2022 record of $5.9 billion. Since 2015, lobbyists at both levels have reported spending over $46 billion. OpenSecrets’ Executive Director, Hilary Braseth, described the cumulative $45 billion spent on lobbying as “staggering.” The organization has also introduced a new tool for the public to track federal and state lobbying expenditures.

Read Full Story
NBC News Rating


Discover more from News Facts Network

Subscribe to get the latest posts sent to your email.

0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x